SCA Pharma to Expand Production Facility in Little Rock

LITTLE ROCK, Ark. (July 21, 2020) – SCA Pharma, an FDA-registered outsourcing facility, today announced that it will expand its operations in Little Rock. SCA will be investing more than $10 million and will create the opportunity to double its current Little Rock workforce of 180 people. Additionally, the investment will allow SCA Pharma to renovate an existing 42,000-square-foot facility at the Clinton National Airport and construct an additional 20,000-square-foot facility adjacent to the existing facility. SCA announced last week that it also plans a 40 percent expansion of its Windsor, Conn. facility.

“We are very pleased that as we continue our geographical expansions in both Arkansas and Connecticut, we can partner with the Arkansas Economic Development Commission (AEDC) and the Little Rock Municipal Airport Commission to solidify and expand the operations of our legacy operations,” said Milton Boyer, CEO of SCA Pharma. “Little Rock has been the foundation that has allowed for our other expansion projects, and this project will bolster that foundation for years to come.”